Farms.com Home   News

Canada and the United Kingdom agree to work together to improve regulatory efficiency for animal vaccines

The Canadian Food Inspection Agency (CFIA) Executive Director of the Animal Health Directorate and Chief Veterinary Officer for Canada, Dr. Mary Jane Ireland, and the United Kingdom's (UK) Veterinary Medicines Directorate (VMD) Deputy Chief Executive Officer, Gavin Hall, issued the following statement:

"We are pleased to announce that the CFIA and the VMD have officially signed a Memorandum of Understanding (MOU) to enhance collaboration between Canada and the UK in the regulatory oversight of veterinary biologics, including animal vaccines. We believe that access to effective veterinary vaccines is critical not only to protect animal health, but to safeguard public health, secure our food supply, and strengthen economic resilience.

This agreement sets out how Canada and the UK will work together to make the pre-market assessment and approval of veterinary biologics more efficient. By sharing scientific expertise and information, discussing common priorities and exploring joint reviews of veterinary biological products, Canada and the UK aim to reduce duplication, lessen the burden on industry and facilitate access to important products.

These efforts will help protect animal health, support farmers and pet owners, and safeguard the food supply chain. The MOU strengthens our commitment to working collaboratively, further develops the strong and productive relationship between our two organisations and reinforces our shared commitment to animal health."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.